About heather

This author has not yet filled in any details.
So far heather has created 733 blog entries.

Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution

cannabis product validation Companies Enter into Strategic Alliance, Referral and Technology Integration Agreement STONY BROOK, N.Y. January 26, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace Technologies, Inc. (CSE: TTT) (“TruTrace”), developer of [...]

Applied DNA Promotes Judy Murrah to COO

STONY BROOK, N.Y. January 20, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah’s expanding range of responsibilities that includes the [...]

2022-10-28T10:30:30-04:00Categories: Press Release|Tags: , |

Linea™ COVID-19 Assay Kit: Detection of Multiple SARS-CoV-2 Variants

STONY BROOK, N.Y. January 19, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™  COVID-19 Assay Kit (the “Assay Kit”) identified COVID-19 positive samples that are variants distinct from the wild-type virus that [...]

Business Update on COVID-19 Diagnostics and Testing

- Average Daily Testing in January 2021 to Date Up 158% Over December 2020, Driven Primarily by Scale Up in Testing Contracts - - Company Increases Production of Assay Kits (Tests) and Sample Collection Kits to Meet Further Demand - - Applied DNA Clinical Laboratories On Track to Request Re-Inspection for CLEP-CLIA [...]

Impact of SARS-CoV-2 69-70del mutation on the Linea™ COVID-19 Assay Kit

Background Mutations are the norm for viruses, especially RNA viruses like SARS-CoV-2. SARS-CoV-2 has been mutating throughout the pandemic. Recently a deletion mutation in the S-gene of SARS-CoV-2 has emerged. The mutation is a 6-nucleotide deletion (21765-21770) within the S-gene that results in the deletion of two [...]

2022-01-19T14:23:07-05:00Categories: Coronavirus|Tags: , |

Closing of $15M Registered Direct Offering

STONY BROOK, N.Y. January 13, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per [...]

2022-10-28T10:52:17-04:00Categories: Press Release|Tags: , |

US FDA lists APDN’s Covid-19 test for virus detection

11 January 2021 (Last Updated January 11th, 2021 10:30) The US Food and Drug Administration (FDA) has published a safety communication that identifies Applied DNA Sciences’ Linea COVID-19 Assay Kit as one of only two tests marketed under its emergency use authorisation (EUA) to detect certain SARS-CoV-2 mutations. [...]

Biden to Release More Doses: Virus Update

Bloomberg NewsJanuary 7, 2021, 6:21 PM EST Corrected January 8, 2021, 4:32 PM EST President-elect Joe Biden says he’ll distribute more of the available doses of coronavirus vaccines, as the U.S. surpassed 4,000 daily fatalities for the first time. New York City has 270,000 unused vaccine doses that it’s seeking to administer to residents over [...]

2022-11-03T15:13:45-04:00Categories: APDN in the News|Tags: , |
Go to Top